Identifying at-risk septic patients in the Emergency Department
Official title: An Observational Pilot Study for the Multi-Modality Risk Prediction and Early Identification of Critically Ill Septic Patients in the Emergency Department
Run by University Hospital Southampton NHS Foundation Trust · NCT06253325 · Data updated 2026-11-12
This study is testing if new monitoring tools and blood tests can help doctors quickly find out which patients with suspected sepsis need critical care when they arrive at the Emergency Department.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Hospital Southampton NHS Foundation Trust Academic / other |
| Locations | 1 site (Southampton, Hampshire) |
| Status | Recruiting |
| Started | January 12, 2024 |
| Main results expected | August 6, 2025 |
| Study ends | August 6, 2025 |
| Registry record updated | December 2, 2024 |
| Trial ID | NCT06253325 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with suspected sepsis and specific clinical indicators of deterioration.
✕Probably not a fit
Patients with traumatic injuries, advanced directives refusing critical care, or those who have received critical care therapies prior to arrival may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to recruit 56 patients suspected of having sepsis upon arrival at the Emergency Department. The investigators will utilize a device to monitor tissue oxygen levels and assess changes when a tourniquet is applied. Additionally, novel blood tests will be conducted alongside routine blood work, and specialized imaging will be performed to evaluate blood flow in small vessels under the tongue. The goal is to determine if this additional data can more effectively identify patients who require critical care.
Why it matters
Potential benefit: If successful, this approach could lead to earlier identification and treatment of septic shock, improving patient outcomes.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in early detection of sepsis using advanced monitoring techniques.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Differential diagnosis which includes infection 2. Change in the quick Sequential Organ Failure Assessment (qSOFA) ≥2 or National Early Warning Score 2 (NEWS2) score ≥5 3. Aged ≥18 years Exclusion Criteria: 1. Traumatic injury 2. Rockwood frailty score ≥6 3. Critical care therapy previously believed to not be in patient's best interests 4. Critical care therapies-initiated pre-hospital. Critical care therapies defined as: 4.1 Mechanical ventilation 4.2 Vasopressor/inotrope therapy 4.3 Sedation or a general anaesthetic 4.4 Pre-hospital transfusion of blood products 4.5 Extra-corporeal support 5. Advanced directive refusing critical care therapies. 6. Acute cardiac failure 7. Active gastrointestinal bleed 8. Massive pulmonary embolism 9. ICU admission declined by critical care team 10. Treated in an acute hospital \<6 hours before presentation to the Emergency Department
Where it's running
-
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, United Kingdom Recruiting
Study contacts
- Principal investigator: James N Ward, BM — University Hospital Southampton NHS Foundation Trust
- Study coordinator: James N Ward, BM
- Email: wardj@doctors.org.uk
- Phone: +447881967336
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care
This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.
-
Early detection of sepsis-related blood clotting problems in severe burn patients
This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.
-
Neutrophil EMR3 as a biomarker for sepsis in ICU patients
Researchers will test whether measuring EMR3 on neutrophils helps diagnose sepsis, monitor progression, and predict outcomes in adults in Chinese ICUs.
-
Thymalfasin added to standard care for adults with sepsis and immune dysfunction
This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.
-
Multicenter group study of sepsis and ARDS in China
This study tests how sepsis and ARDS differ among adults across several Chinese hospitals and builds a biobank to understand why some patients do better or worse.
-
Non-invasive hemodynamic guidance for sepsis care on medical wards
This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.